The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Rotavirus Vaccines-Global Market Insights and Sales Trends 2025
Synopsis
Rotavirus vaccine is a vaccine used to protect against rotavirus infections, which are the leading cause of severe diarrhea among young children. The vaccines prevent 15–34% of severe diarrhea in the developing world and 37–96% of severe diarrhea in the developed world. The vaccines decrease the risk of death among young children due to diarrhea. Immunizing babies decreases rates of disease among older people and those who have not been immunized.
The World Health Organization (WHO) recommends that rotavirus vaccine be included in national routine vaccinations programs, especially in areas where the disease is common. This should be done along with promoting breastfeeding, handwashing, clean water and good sanitation. It is given by mouth and requires two or three doses. It should be given starting around six weeks of age.
The vaccines are safe. This includes their use in people with HIV/AIDS. An earlier vaccine that is no longer used was linked to intussusception, but the current versions are not clearly linked. Due to a potential risk they are not recommended in babies who have had intussusception. The vaccines are made from weakened rotavirus.
The vaccine first became available in the United States in 2006. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. The wholesale cost in the developing world is between US$6.96 and $20.66 per dose as of 2014.In the United States it is more than US$200. As of 2013 there are two types of vaccine available globally, Rotarix and RotaTeq. Others are used in some countries.
The global Rotavirus Vaccines market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Rotavirus Vaccines in various end use industries. The expanding demands from the Adult and Pediatric, are propelling Rotavirus Vaccines market. Rotarix, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the RotaTeq segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Rotavirus Vaccines, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Rotavirus Vaccines market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Rotavirus Vaccines market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Rotavirus Vaccines sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Rotavirus Vaccines covered in this report include Bharat Biotech, Merck & Co., Inc, GlaxoSmithKline plc, Lanzhou Institute of Biological and Bharat Biotech International Limited, etc.
The global Rotavirus Vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bharat Biotech
Merck & Co., Inc
GlaxoSmithKline plc
Lanzhou Institute of Biological
Bharat Biotech International Limited
Global Rotavirus Vaccines market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Rotavirus Vaccines market, Segment by Type:
Rotarix
RotaTeq
Rotavac
Rotavin-M1
Lanzhou lamb
Others
Global Rotavirus Vaccines market, by Application
Adult
Pediatric
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Rotavirus Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Rotavirus Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Rotavirus vaccine is a vaccine used to protect against rotavirus infections, which are the leading cause of severe diarrhea among young children. The vaccines prevent 15–34% of severe diarrhea in the developing world and 37–96% of severe diarrhea in the developed world. The vaccines decrease the risk of death among young children due to diarrhea. Immunizing babies decreases rates of disease among older people and those who have not been immunized.
The World Health Organization (WHO) recommends that rotavirus vaccine be included in national routine vaccinations programs, especially in areas where the disease is common. This should be done along with promoting breastfeeding, handwashing, clean water and good sanitation. It is given by mouth and requires two or three doses. It should be given starting around six weeks of age.
The vaccines are safe. This includes their use in people with HIV/AIDS. An earlier vaccine that is no longer used was linked to intussusception, but the current versions are not clearly linked. Due to a potential risk they are not recommended in babies who have had intussusception. The vaccines are made from weakened rotavirus.
The vaccine first became available in the United States in 2006. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. The wholesale cost in the developing world is between US$6.96 and $20.66 per dose as of 2014.In the United States it is more than US$200. As of 2013 there are two types of vaccine available globally, Rotarix and RotaTeq. Others are used in some countries.
The global Rotavirus Vaccines market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Rotavirus Vaccines in various end use industries. The expanding demands from the Adult and Pediatric, are propelling Rotavirus Vaccines market. Rotarix, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the RotaTeq segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Rotavirus Vaccines, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Rotavirus Vaccines market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Rotavirus Vaccines market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Rotavirus Vaccines sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Rotavirus Vaccines covered in this report include Bharat Biotech, Merck & Co., Inc, GlaxoSmithKline plc, Lanzhou Institute of Biological and Bharat Biotech International Limited, etc.
The global Rotavirus Vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bharat Biotech
Merck & Co., Inc
GlaxoSmithKline plc
Lanzhou Institute of Biological
Bharat Biotech International Limited
Global Rotavirus Vaccines market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Rotavirus Vaccines market, Segment by Type:
Rotarix
RotaTeq
Rotavac
Rotavin-M1
Lanzhou lamb
Others
Global Rotavirus Vaccines market, by Application
Adult
Pediatric
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Rotavirus Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Rotavirus Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Rotavirus Vaccines Market Overview
1.1 Rotavirus Vaccines Product Overview
1.2 Rotavirus Vaccines Market Segment by Type
1.2.1 Rotarix
1.2.2 RotaTeq
1.2.3 Rotavac
1.2.4 Rotavin-M1
1.2.5 Lanzhou lamb
1.2.6 Others
1.3 Global Rotavirus Vaccines Market Size by Type
1.3.1 Global Rotavirus Vaccines Market Size Overview by Type (2018-2029)
1.3.2 Global Rotavirus Vaccines Historic Market Size Review by Type (2018-2023)
1.3.3 Global Rotavirus Vaccines Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Rotavirus Vaccines Sales Breakdown by Type (2018-2023)
1.4.2 Europe Rotavirus Vaccines Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Rotavirus Vaccines Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Rotavirus Vaccines Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Rotavirus Vaccines Sales Breakdown by Type (2018-2023)
2 Global Rotavirus Vaccines Market Competition by Company
2.1 Global Top Players by Rotavirus Vaccines Sales (2018-2023)
2.2 Global Top Players by Rotavirus Vaccines Revenue (2018-2023)
2.3 Global Top Players by Rotavirus Vaccines Price (2018-2023)
2.4 Global Top Manufacturers Rotavirus Vaccines Manufacturing Base Distribution, Sales Area, Product Type
2.5 Rotavirus Vaccines Market Competitive Situation and Trends
2.5.1 Rotavirus Vaccines Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Rotavirus Vaccines Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Rotavirus Vaccines as of 2022)
2.7 Date of Key Manufacturers Enter into Rotavirus Vaccines Market
2.8 Key Manufacturers Rotavirus Vaccines Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Rotavirus Vaccines Status and Outlook by Region
3.1 Global Rotavirus Vaccines Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Rotavirus Vaccines Historic Market Size by Region
3.2.1 Global Rotavirus Vaccines Sales in Volume by Region (2018-2023)
3.2.2 Global Rotavirus Vaccines Sales in Value by Region (2018-2023)
3.2.3 Global Rotavirus Vaccines Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Rotavirus Vaccines Forecasted Market Size by Region
3.3.1 Global Rotavirus Vaccines Sales in Volume by Region (2024-2029)
3.3.2 Global Rotavirus Vaccines Sales in Value by Region (2024-2029)
3.3.3 Global Rotavirus Vaccines Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Rotavirus Vaccines by Application
4.1 Rotavirus Vaccines Market Segment by Application
4.1.1 Adult
4.1.2 Pediatric
4.2 Global Rotavirus Vaccines Market Size by Application
4.2.1 Global Rotavirus Vaccines Market Size Overview by Application (2018-2029)
4.2.2 Global Rotavirus Vaccines Historic Market Size Review by Application (2018-2023)
4.2.3 Global Rotavirus Vaccines Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Rotavirus Vaccines Sales Breakdown by Application (2018-2023)
4.3.2 Europe Rotavirus Vaccines Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Rotavirus Vaccines Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Rotavirus Vaccines Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Rotavirus Vaccines Sales Breakdown by Application (2018-2023)
5 North America Rotavirus Vaccines by Country
5.1 North America Rotavirus Vaccines Historic Market Size by Country
5.1.1 North America Rotavirus Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Rotavirus Vaccines Sales in Volume by Country (2018-2023)
5.1.3 North America Rotavirus Vaccines Sales in Value by Country (2018-2023)
5.2 North America Rotavirus Vaccines Forecasted Market Size by Country
5.2.1 North America Rotavirus Vaccines Sales in Volume by Country (2024-2029)
5.2.2 North America Rotavirus Vaccines Sales in Value by Country (2024-2029)
6 Europe Rotavirus Vaccines by Country
6.1 Europe Rotavirus Vaccines Historic Market Size by Country
6.1.1 Europe Rotavirus Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Rotavirus Vaccines Sales in Volume by Country (2018-2023)
6.1.3 Europe Rotavirus Vaccines Sales in Value by Country (2018-2023)
6.2 Europe Rotavirus Vaccines Forecasted Market Size by Country
6.2.1 Europe Rotavirus Vaccines Sales in Volume by Country (2024-2029)
6.2.2 Europe Rotavirus Vaccines Sales in Value by Country (2024-2029)
7 Asia-Pacific Rotavirus Vaccines by Region
7.1 Asia-Pacific Rotavirus Vaccines Historic Market Size by Region
7.1.1 Asia-Pacific Rotavirus Vaccines Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Rotavirus Vaccines Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Rotavirus Vaccines Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Rotavirus Vaccines Forecasted Market Size by Region
7.2.1 Asia-Pacific Rotavirus Vaccines Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Rotavirus Vaccines Sales in Value by Region (2024-2029)
8 Latin America Rotavirus Vaccines by Country
8.1 Latin America Rotavirus Vaccines Historic Market Size by Country
8.1.1 Latin America Rotavirus Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Rotavirus Vaccines Sales in Volume by Country (2018-2023)
8.1.3 Latin America Rotavirus Vaccines Sales in Value by Country (2018-2023)
8.2 Latin America Rotavirus Vaccines Forecasted Market Size by Country
8.2.1 Latin America Rotavirus Vaccines Sales in Volume by Country (2024-2029)
8.2.2 Latin America Rotavirus Vaccines Sales in Value by Country (2024-2029)
9 Middle East and Africa Rotavirus Vaccines by Country
9.1 Middle East and Africa Rotavirus Vaccines Historic Market Size by Country
9.1.1 Middle East and Africa Rotavirus Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Rotavirus Vaccines Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Rotavirus Vaccines Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Rotavirus Vaccines Forecasted Market Size by Country
9.2.1 Middle East and Africa Rotavirus Vaccines Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Rotavirus Vaccines Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Bharat Biotech
10.1.1 Bharat Biotech Company Information
10.1.2 Bharat Biotech Introduction and Business Overview
10.1.3 Bharat Biotech Rotavirus Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Bharat Biotech Rotavirus Vaccines Products Offered
10.1.5 Bharat Biotech Recent Development
10.2 Merck & Co., Inc
10.2.1 Merck & Co., Inc Company Information
10.2.2 Merck & Co., Inc Introduction and Business Overview
10.2.3 Merck & Co., Inc Rotavirus Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Merck & Co., Inc Rotavirus Vaccines Products Offered
10.2.5 Merck & Co., Inc Recent Development
10.3 GlaxoSmithKline plc
10.3.1 GlaxoSmithKline plc Company Information
10.3.2 GlaxoSmithKline plc Introduction and Business Overview
10.3.3 GlaxoSmithKline plc Rotavirus Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.3.4 GlaxoSmithKline plc Rotavirus Vaccines Products Offered
10.3.5 GlaxoSmithKline plc Recent Development
10.4 Lanzhou Institute of Biological
10.4.1 Lanzhou Institute of Biological Company Information
10.4.2 Lanzhou Institute of Biological Introduction and Business Overview
10.4.3 Lanzhou Institute of Biological Rotavirus Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Lanzhou Institute of Biological Rotavirus Vaccines Products Offered
10.4.5 Lanzhou Institute of Biological Recent Development
10.5 Bharat Biotech International Limited
10.5.1 Bharat Biotech International Limited Company Information
10.5.2 Bharat Biotech International Limited Introduction and Business Overview
10.5.3 Bharat Biotech International Limited Rotavirus Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Bharat Biotech International Limited Rotavirus Vaccines Products Offered
10.5.5 Bharat Biotech International Limited Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Rotavirus Vaccines Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Rotavirus Vaccines Industrial Chain Analysis
11.4 Rotavirus Vaccines Market Dynamics
11.4.1 Rotavirus Vaccines Industry Trends
11.4.2 Rotavirus Vaccines Market Drivers
11.4.3 Rotavirus Vaccines Market Challenges
11.4.4 Rotavirus Vaccines Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Rotavirus Vaccines Distributors
12.3 Rotavirus Vaccines Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
